Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 1329.HK
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 0.61 0.61
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 69.82 -51.76 -171.49
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.00 1.71 1.71
Cash 0.00 0.58 0.58
Capex 0.00 < 0.005 < 0.005
Free Cash Flow 0.00 0.13 0.13
Revenue 0.00 0.29 0.29
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 0.08 0.08
Operating Margin 0.00 -0.08 -0.08
ROA 0.00 < 0.005 < 0.005
ROE 0.00 -0.01 -0.01
ROIC -68.37 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 1329.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 1329.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 1329.HK is permitted for members.